Bragar Eagel Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Humanigen, Latch, Azure, and Abbott and Encourages Investors to Contact the Firm
NEW YORK, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Humanigen, Inc. (NASDAQ: HGEN), Latch, Inc. (NASDAQ: LTCH), Azure Power Global Limited (NYSE: AZRE), and Abbott Laboratories (NYSE: ABT). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Bragar Eagel Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Humanigen, Latch, Azure, and Abbott and Encourages Investors to Contact the Firm
NEW YORK, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Humanigen, Inc. (NASDAQ: HGEN), Latch, Inc. (NASDAQ: LTCH), Azure Power Global Limited (NYSE: AZRE), and Abbott Laboratories (NYSE: ABT). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.